Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2400 participants.
Also called NCT01245608
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 2,400 participants
- Registry
-
NCT01245608
-
- Other papers using this trial's data
- Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Iran
- Registry status
- Completed
Technical summary
Registry record NCT01245608. Randomized; single masking; primary purpose prevention. Start 2011-10 (actual); primary completion 2018-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
- Acronym
- PolyIran-L
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Polypill
- Lead sponsor
- Tehran University of Medical Sciences
- Collaborator
- Golestan University of Medical sciences
- Collaborator
- University of Birmingham
Record details
- Record id
cardio:ct-nct01245608- Content hash
bd2fd22b0087f1a5e1426f6e911aef83978f3ce35ba0f2629447f6333d411943